Dr. Patrick S. Hume, MD, PHD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- University of Colorado School of Medicine, Denver (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 92
Licensed in Colorado since 2017, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Colorado School of Medicine, Denver
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
CO license 58547 (first issued 2017; active) -
Pulmonary Disease Physician
CO license 58547 (first issued 2017; active) · CO license TL.005947
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- National Jewish Health Denver, CO
Medical groups
- National Jewish Health (247 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 92
- Services billed
- 147
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 22 | 20 |
| New patient office or other outpatient visit, 60-74 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Denver, CO | 84 |
| Prolastin C (alpha-1-proteinase inhibitor) | 50 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Denver, CO | 40 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Denver, CO | 39 |
| Prednisone Other prescribers in Denver, CO | 30 |
| Roflumilast Other prescribers in Denver, CO | 25 |
| Azithromycin Other prescribers in Denver, CO | 24 |
| Omeprazole Other prescribers in Denver, CO | 17 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Denver, CO | 15 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Denver, CO | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 4 payments worth $1,091 in total to this clinician.
| Takeda Pharmaceuticals U.S.A., Inc. | $984 |
|---|---|
| Genzyme Corporation | $107 |
| Consulting Fee | $984 |
|---|---|
| Food and Beverage | $107 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. Feb 28, 2025 | Consulting Fee GLASSIA · IMMUNOLOGY | $984 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.